Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Brugia malayi | Carboxylesterase family protein | 0.009 | 0.1508 | 0.1508 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.009 | 0.1508 | 0.5 |
Echinococcus multilocularis | neuroligin | 0.009 | 0.1508 | 0.1508 |
Echinococcus granulosus | carboxylesterase 5A | 0.0535 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.009 | 0.1508 | 0.1508 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.009 | 0.1508 | 0.1508 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.009 | 0.1508 | 0.1508 |
Loa Loa (eye worm) | carboxylesterase | 0.0535 | 1 | 1 |
Schistosoma mansoni | gliotactin | 0.009 | 0.1508 | 0.1508 |
Onchocerca volvulus | 0.009 | 0.1508 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.009 | 0.1508 | 0.1508 |
Onchocerca volvulus | 0.009 | 0.1508 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Brugia malayi | Carboxylesterase family protein | 0.009 | 0.1508 | 0.1508 |
Echinococcus granulosus | acetylcholinesterase | 0.0535 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0535 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Brugia malayi | Carboxylesterase family protein | 0.009 | 0.1508 | 0.1508 |
Loa Loa (eye worm) | hypothetical protein | 0.0535 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0535 | 1 | 1 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.009 | 0.1508 | 0.5 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.009 | 0.1508 | 0.1508 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.009 | 0.1508 | 0.1508 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.009 | 0.1508 | 0.1508 |
Onchocerca volvulus | 0.009 | 0.1508 | 1 | |
Onchocerca volvulus | 0.009 | 0.1508 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Loa Loa (eye worm) | carboxylesterase | 0.009 | 0.1508 | 0.1508 |
Onchocerca volvulus | 0.009 | 0.1508 | 1 | |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.009 | 0.1508 | 0.5 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.009 | 0.1508 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.009 | 0.1508 | 0.1508 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.009 | 0.1508 | 0.1508 |
Schistosoma mansoni | acetylcholinesterase | 0.009 | 0.1508 | 0.1508 |
Echinococcus granulosus | acetylcholinesterase | 0.0535 | 1 | 1 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.009 | 0.1508 | 0.5 |
Echinococcus granulosus | BC026374 protein S09 family | 0.009 | 0.1508 | 0.1508 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.009 | 0.1508 | 0.1508 |
Loa Loa (eye worm) | hypothetical protein | 0.0535 | 1 | 1 |
Echinococcus granulosus | neuroligin | 0.009 | 0.1508 | 0.1508 |
Brugia malayi | Carboxylesterase family protein | 0.009 | 0.1508 | 0.1508 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Echinococcus multilocularis | acetylcholinesterase | 0.0535 | 1 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0535 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0535 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0535 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1508 | 0.1508 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.009 | 0.1508 | 0.1508 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.009 | 0.1508 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.